Results 171 to 180 of about 30,345 (207)

Minocycline infusion sclerotherapy for infected hepatic cysts in a patient with autosomal dominant polycystic kidney disease: a case report and literature review. [PDF]

CEN Case Rep
Inamura Y, Fukunaga S, Matsuo N, Maruyama Y, Yokoo T.   +4 more
europepmc   +1 more source

Genetic Disorders Detectable by Fetal MRI: A Review. [PDF]

Diagnostics (Basel)
Wong KC, Chow TH, Cheung C, Chan JPK, Lee JCY, Kan EYL, Chu WCW.   +6 more
europepmc   +1 more source

Somatostatin analog therapy in delaying progression of polycystic liver disease: A meta-analysis with trial sequential analysis. [PDF]

ILIVER
Beshr MS, Shembesh RH, Sawaf B, Abbarh S, Abu-Rumaileh M, Tincopa M, Elhadi M.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Autosomal dominant polycystic kidney disease

The Lancet, 2007
Autosomal dominant polycystic kidney disease is the most prevalent, potentially lethal, monogenic disorder. It is associated with large interfamilial and intrafamilial variability, which can be explained to a large extent by its genetic heterogeneity and modifier genes.
Vicente E, Torres, Peter C, Harris, Yves, Pirson   +2 more
openaire   +4 more sources

Autosomal Dominant Polycystic Kidney Disease

Primary Care: Clinics in Office Practice, 2020
Autosomal Dominant Polycystic Kidney Disease is an inherited multisystemic disorder of the renal tubules with subsequent formation of multiple cysts and enlargement of the kidney, affecting various organs. Diagnosis is initially suspected in those with family history and/or individuals who develop hypertension early on (secondary hypertension) or ...
Parvathi, Perumareddi, Darin P, Trelka
openaire   +3 more sources

Autosomal Dominant Polycystic Kidney Disease

Advances in Kidney Disease and Health
Over 50% of people affected with autosomal dominant polycystic kidney disease (ADPKD) will develop kidney failure, making ADPKD the 4th most common cause of end-stage kidney disease. ADPKD is a systemic condition affecting the kidneys, liver, heart, vasculature, and other organ systems.
Maria Lourdes Gonzalez Suarez, Silvia Titan, Neera K. Dahl   +2 more
  +6 more sources

Autosomal Dominant Polycystic Kidney Disease

New England Journal of Medicine, 1990
Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disease occurring in 1 in 200 to 1 in 1,000 individuals. ADPKD is characterized by cystic lesions in the kidneys and often by structural abnormalities in the gastrointestinal tract and cardiovascular system.
openaire   +3 more sources

Autosomal dominant polycystic kidney disease

2018
Based on an estimated population prevalence of between 1 in 400 and 1 in 1000, there are over 60,000 individuals with or at risk of developing complications associated with autosomal dominant polycystic kidney disease (ADPKD) in the United Kingdom. This equates to over 300,000 people in the United States and 7 million worldwide.
Albert C. M. Ong, Richard Sandford
openaire   +2 more sources